An excellent week for Dunedin-based cancer diagnostic company
Pacific Edge got even better last night when it won the
supreme award at the New Zealand Innovators Awards in
The Dunedin company had earlier enjoyed a big spike in its
share price after it announced that it was signing up a key
United States client, FedMed, a national health network
servicing 40 million Americans. Pacific Edge chief executive
David Darling, who had yesterday just flown back to New
Zealand from the United States, said the outcome was
''fantastic'' for the firm -''it's been a great week for
The firm won the top award with its innovative product
Cxbladder, a novel gene test for the detection and management
of bladder cancer.
The supreme award, which comes with a trophy and intellectual
property advice valued at $5000, was ''tremendous
recognition'' for the Dunedin team. It was rare for the same
team of people to have gone from ''discovery science'' to
successful product development, Mr Darling said.
Several members of the team had been in Auckland for the
awards, but Prof Parry Guilford, the firm's chief scientific
officer and a principal investigator at the University of
Otago's Cancer Genetics Laboratory, had been unable to
The firm's new gene test also won the Innovation in Health
and Science award last night.